The rise of Viagra initially sparked a surge for pharma, but recent shifts present a murky outlook for investors. Lower-cost competitors are eroding earnings, and continued legal battles add additional complexity to https://joanaapa887632.dreamyblogs.com/41486687/the-blue-pill-and-pharma-a-risky-bet